In Alzheimer’s disease (AD) and other dementias, a reduction in astrocytic GLT-1 and GLAST is observed in animal models and postmortem tissue, and is also a feature of ageing, the strongest risk factor for AD and other neurodegenerative diseases [24,30]. This evidence concerns the gene SLC1A3 and Alzheimer disease.